PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 51 filers reported holding PLX PHARMA INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,000 | -85.3% | 29,962 | -43.6% | 0.00% | – |
| Q2 2022 | $129,000 | -82.2% | 53,127 | -70.4% | 0.00% | -100.0% |
| Q1 2022 | $724,000 | -68.1% | 179,227 | -36.8% | 0.00% | -60.0% |
| Q4 2021 | $2,271,000 | -44.9% | 283,517 | +32.7% | 0.01% | -50.0% |
| Q3 2021 | $4,124,000 | +1394.2% | 213,655 | +968.3% | 0.01% | +900.0% |
| Q2 2021 | $276,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $346,000 | 0.38% |
| Park West Asset Management LLC | 1,473,218 | $8,132,000 | 0.17% |
| Heritage Way Advisors, LLC | 41,712 | $230,000 | 0.11% |
| Cranbrook Wealth Management, LLC | 7,500 | $41,000 | 0.01% |
| 683 Capital Management, LLC | 30,000 | $166,000 | 0.01% |
| Renaissance Technologies | 139,083 | $768,000 | 0.00% |
| FAYEZ SAROFIM & CO | 13,729 | $76,000 | 0.00% |
| CREDIT SUISSE AG/ | 27,394 | $151,000 | 0.00% |
| MORGAN STANLEY | 250 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 438 | $2,000 | 0.00% |